Back to mobile site

Ionis Pharmaceuticals (IONS) PT Raised at Bernstein Ahead of a Catalyst-Rich 2H26

February 26, 2026 5:53 AM EST Send to a Friend
Bernstein SocGen Group analyst William Pickering raised the price target on Ionis Pharmaceuticals (NASDAQ: IONS) to $90.00 (from $89.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login